TUMOR-NECROSIS-FACTOR-ALPHA CAUSES MYOCARDIAL DEPRESSION IN GUINEA-PIGS

被引:36
作者
HEARD, SO [1 ]
PERKINS, MW [1 ]
FINK, MP [1 ]
机构
[1] UNIV MASSACHUSETTS, MED CTR, DEPT SURG, WORCESTER, MA 01655 USA
关键词
TUMOR NECROSIS FACTOR; NOREPINEPHRINE; HEART ATRIUM; MYOCARDIAL CONTRACTION; MYOCARDIAL DISEASES; SEPTICEMIA; CATECHOLAMINES; CYTOKINES; GUINEA PIG; DOSE RESPONSE RELATIONSHIP; DRUG;
D O I
10.1097/00003246-199204000-00015
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background and Methods: Tumor necrosis factor-alpha (TNF-alpha) is an important mediator of metabolic and cardiovascular derangements in sepsis and endotoxicosis. We tested the hypothesis that TNF-alpha causes myocardial depression and alters the cardiac responsiveness to administered norepinephrine. Albino Hartley guinea pigs (n = 32) of either sex were injected iv with saline (1.5 mL) or recombinant human TNF-alpha (1 mg/kg). At 6, 24, or 72 hrs after injection, atria were harvested, split, connected to force displacement x transducer-amplifier-recorder systems and maintained in vitro in oxygenated 37.5-degrees-C Krebs-Henseleit buffer. Results: Maximal left atrial force of contraction and maximal left atrial velocity of contraction were decreased in the TNF-alpha treated animals compared with controls (p < .05), irrespective of time after TNF-alpha injection. There were no differences between groups for left atrial maximal velocity of relaxation and right atrial rate. The norepinephrine concentration that elicited a 50% maximal left atrial contractile response (ED50) was higher in TNF-alpha treated animals compared with controls (p < .05). Maximal left atrial force of contraction, maximal right atrial rate, and right atrial ED50 were similar in the two groups. Conclusions: These results indicate that TNF-alpha injected in vivo causes in vitro myocardial depression and alters cardiac responsiveness to norepinephrine.
引用
收藏
页码:523 / 527
页数:5
相关论文
共 34 条
[1]   ENDOTOXIN-INDUCED MYOCARDIAL DEPRESSION IN RATS - EFFECT OF IBUPROFEN AND SDZ-64-688, A PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST [J].
BAUM, TD ;
HEARD, SO ;
FELDMAN, HS ;
LATKA, CA ;
FINK, MP .
JOURNAL OF SURGICAL RESEARCH, 1990, 48 (06) :629-634
[2]   TUMOR-NECROSIS-FACTOR MEDIATES ENDOTOXIC EFFECTS IN MICE [J].
BAUSS, F ;
DROGE, W ;
MANNEL, DN .
INFECTION AND IMMUNITY, 1987, 55 (07) :1622-1625
[3]   THE COMMON MEDIATOR OF SHOCK, CACHEXIA, AND TUMOR NECROSIS [J].
BEUTLER, B ;
CERAMI, A .
ADVANCES IN IMMUNOLOGY, 1988, 42 :213-231
[4]  
BEUTLER B, 1987, CLIN RES, V35, P192
[5]   PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN [J].
BEUTLER, B ;
MILSARK, IW ;
CERAMI, AC .
SCIENCE, 1985, 229 (4716) :869-871
[6]  
BLINKS JR, 1966, J PHARMACOL EXP THER, V151, P221
[7]  
Carli A, 1983, Adv Shock Res, V10, P161
[8]   TUMOR NECROSIS FACTOR (CACHECTIN) INDUCES PHOSPHOLIPASE-A2 ACTIVITY AND SYNTHESIS OF A PHOSPHOLIPASE-A2-ACTIVATING PROTEIN IN ENDOTHELIAL-CELLS [J].
CLARK, MA ;
CHEN, MJ ;
CROOKE, ST ;
BOMALASKI, JS .
BIOCHEMICAL JOURNAL, 1988, 250 (01) :125-132
[9]   TUMOR NECROSIS FACTOR AND INTERLEUKIN-1 SERUM LEVELS DURING SEVERE SEPSIS IN HUMANS [J].
DAMAS, P ;
REUTER, A ;
GYSEN, P ;
DEMONTY, J ;
LAMY, M ;
FRANCHIMONT, P .
CRITICAL CARE MEDICINE, 1989, 17 (10) :975-978
[10]   PLASMA TUMOR NECROSIS FACTOR AND MORTALITY IN CRITICALLY ILL SEPTIC PATIENTS [J].
DEBETS, JMH ;
KAMPMEIJER, R ;
VANDERLINDEN, MPMH ;
BUURMAN, WA ;
VANDERLINDEN, CJ .
CRITICAL CARE MEDICINE, 1989, 17 (06) :489-494